Skip to main content
Fig. 1 | BMC Complementary Medicine and Therapies

Fig. 1

From: Feikang granules ameliorate pulmonary inflammation in the rat model of chronic obstructive pulmonary disease via TLR2/4-mediated NF-κB pathway

Fig. 1

Feikang granules improved pulmonary function in the COPD model rats. The peak of inspiratory flow (PIF), peak of expiratory flow (PEF), and 50% tidal volume expiratory flow (EF50) were measured in all groups of COPD model rats: Normal control rats (con, n = 4), COPD model rats without any treatment (Mod, n = 6), low (n = 5), middle(n = 5) and high (n = 5) dose of Feikang granules groups and dexamethasone group (Dex, n = 5)

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us